What is AbbVie (ABBV)?
AbbVie is a global biopharmaceutical company that focuses on developing and commercializing advanced therapies in various therapeutic areas. Its portfolio includes treatments for immunology, oncology, neuroscience, virology, and other medical conditions. AbbVie invests in research and development to discover innovative medicines and improve patient outcomes. The company operates manufacturing sites and research facilities worldwide. It collaborates with healthcare providers, academic institutions, and other organizations to advance medical science. AbbVie’s products include biologics, small molecules, and specialty pharmaceuticals. The company plays a significant role in the pharmaceutical industry, addressing complex diseases through its scientific expertise and therapeutic solutions.
AbbVie Stock Price Today: Live Overview
The price today is shaped by market fluctuations, with AbbVie trading at $205.74. The price has varied between $202.98 and $207.64 during the session, changing by -0.4506% so far.
FAQ: AbbVie (ABBV)
What is the current price of ABBV stock?
AbbVie's current trading price is $205.74.
Does ABBV pay dividends?
AbbVie pays dividends via cash distributions (if applicable).
Does ABBV have a formal corporate presence or regional headquarters in the UAE?
AbbVie maintains a regional office in Dubai Internet City, UAE.
What is ABBV best known for?
AbbVie is most famous for its pharmaceutical products including Humira and Imbruvica.
What assets are typically shown together with ABBV?
Commonly shown alongside ABBV: Daiichi Sankyo Company, Limited, Recordati, BioMarin
Latest shares articles



